CAM
FOLD

Close Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Close Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-600
Closed -$9K – 270
2026
Q1 		$9K Hold
600
– – ﹤0.01% 230
2025
Q4 		$9K Hold
600
– – ﹤0.01% 231
2025
Q3 		$5K Hold
600
– – ﹤0.01% 245
2025
Q2 		$3K Hold
600
– – ﹤0.01% 236
2025
Q1 		$5K Hold
600
– – ﹤0.01% 229
2024
Q4 		$6K Hold
600
– – ﹤0.01% 221
2024
Q3 		$6K Hold
600
– – ﹤0.01% 232
2024
Q2 		$6K Hold
600
– – ﹤0.01% 233
2024
Q1 		$7K Hold
600
– – ﹤0.01% 230
2023
Q4 		$9K Hold
600
– – ﹤0.01% 212
2023
Q3 		$7K Buy
+600
New +$7.74K ﹤0.01% 211

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Close Asset Management's FOLD Position: Q2 2026 in Review

Close Asset Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 600 shares — an estimated $9K sold.

Close Asset Management first reported a position in FOLD in Q3 2023 and held it in 11 quarters. The position peaked at $9K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Close Asset Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Close Asset Management sold 600 Amicus Therapeutics shares in Q2 2026, an estimated $9K.
  • Close Asset Management first reported a position in Amicus Therapeutics in Q3 2023 and held it in 11 quarters.
  • Close Asset Management's Amicus Therapeutics position peaked at $9K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Close Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.